BeiGene Ltd (BGNE) Insider Trading
- $1,001,233,203.74
- $1,056,142,043.54
- April 10, 2024
- John Oyler
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 1, 2019 | CEO | 2,824 | $125.18 | Sell | $353,508.32 | |
April 8, 2019 | CMO | 14,130 | $142.77 | Sell | $2,017,340.10 | |
March 14, 2019 | Director | 14,973 | $136.10 | Sell | $2,037,825.30 | |
March 11, 2019 | CMO | 2,636 | $130.28 | Sell | $343,418.08 | |
March 7, 2019 | CMO | 71 | $140.50 | Sell | $9,975.50 | |
March 6, 2019 | CEO | 25,499 | $151.73 | Sell | $3,868,963.27 | |
March 4, 2019 | CEO | 4,588 | $152.01 | Sell | $697,421.88 | |
March 1, 2019 | Director | 5,000 | $146.82 | Sell | $734,100.00 | |
Dec. 18, 2018 | CMO | 20,000 | $133.68 | Sell | $2,673,600.00 | |
Dec. 10, 2018 | CEO | 4,138 | $135.78 | Sell | $561,857.64 | |
Dec. 3, 2018 | Director | 5,000 | $152.41 | Sell | $762,050.00 | |
Nov. 28, 2018 | CEO | 29,195 | $143.66 | Sell | $4,194,153.70 | |
Nov. 26, 2018 | CMO | 3,000 | $139.58 | Sell | $418,740.00 | |
Nov. 26, 2018 | CEO | 9,078 | $139.06 | Sell | $1,262,386.68 | |
Nov. 19, 2018 | Director | 5,000 | $124.30 | Sell | $621,500.00 | |
Nov. 12, 2018 | CMO | 40,000 | $120.20 | Sell | $4,808,000.00 | |
Nov. 8, 2018 | CMO | 14,711 | $126.07 | Sell | $1,854,615.77 | |
Sept. 4, 2018 | CMO | 2,911 | $174.60 | Sell | $508,260.60 | |
Aug. 30, 2018 | Director | 2,000 | $179.00 | Sell | $358,000.00 | |
Aug. 23, 2018 | CMO | 5,769 | $169.12 | Sell | $975,653.28 | |
Aug. 13, 2018 | Director | 3,449 | $158.77 | Sell | $547,597.73 | |
Aug. 2, 2018 | Director | 5,814,100 | $108.00 | Buy | $627,922,800.00 | |
July 16, 2018 | CEO | 2,550 | $164.12 | Sell | $418,506.00 | |
March 19, 2018 | CFO | 40,000 | $160.27 | Sell | $6,410,800.00 | |
March 16, 2018 | CFO | 10,872 | $157.07 | Sell | $1,707,665.04 | |
March 2, 2018 | CEO | 99,000 | $145.63 | Sell | $14,417,370.00 | |
Feb. 28, 2018 | EVP | 10,000 | $146.88 | Sell | $1,468,800.00 | |
Feb. 28, 2018 | CEO | 34,338 | $146.69 | Sell | $5,037,041.22 | |
Jan. 18, 2018 | Director | 1,980,198 | $101.00 | Buy | $199,999,998.00 | |
Dec. 26, 2017 | CEO | 20,137 | $96.46 | Sell | $1,942,415.02 | |
Dec. 21, 2017 | CMO | 1,000 | $98.00 | Sell | $98,000.00 | |
Dec. 13, 2017 | CMO | 1,500 | $94.25 | Sell | $141,375.00 | |
Dec. 8, 2017 | CEO | 144,000 | $93.95 | Sell | $13,528,800.00 | |
Dec. 6, 2017 | CEO | 31,446 | $92.29 | Sell | $2,902,151.34 | |
Dec. 4, 2017 | CMO | 1,100 | $86.00 | Sell | $94,600.00 | |
Nov. 29, 2017 | CEO | 85,906 | $84.66 | Sell | $7,272,801.96 | |
Nov. 27, 2017 | CEO | 16,581 | $86.76 | Sell | $1,438,567.56 | |
Nov. 20, 2017 | CMO | 1,600 | $86.25 | Sell | $138,000.00 | |
Nov. 16, 2017 | CMO | 600 | $85.00 | Sell | $51,000.00 | |
Nov. 15, 2017 | CEO | 150,957 | $80.50 | Sell | $12,152,038.50 | |
Nov. 13, 2017 | CMO | 3,601 | $82.96 | Sell | $298,738.96 | |
Nov. 13, 2017 | CEO | 25,054 | $83.06 | Sell | $2,080,985.24 | |
Aug. 11, 2017 | Director | 176,056 | $71.00 | Buy | $12,499,976.00 | |
July 12, 2017 | Director | 20,000 | $72.44 | Sell | $1,448,800.00 | |
July 10, 2017 | Director | 10,810 | $72.15 | Sell | $779,941.50 | |
July 6, 2017 | CEO | 219,400 | $64.82 | Sell | $14,221,508.00 | |
June 28, 2017 | Director | 35,000 | $44.95 | Sell | $1,573,250.00 | |
June 23, 2017 | CEO | 98,500 | $44.16 | Sell | $4,349,760.00 | |
June 2, 2017 | Director | 5,539 | $40.00 | Sell | $221,560.00 | |
May 4, 2017 | Director | 14,461 | $40.80 | Sell | $590,008.80 |
Insiders are both buying and selling BeiGene Ltd stock.
The insider traders at BeiGene Ltd are: John Oyler, Jane Huang, Xiaodong Wang, Xiaobin Wu, Howard Liang, Lai Wang, Donald W Glazer, Julia Aijun Wang, Bros. Advisors Lp Baker, Amy C Peterson, Timothy Yung-Cheng Chen, Advisors Ltd. Hhlr, Ji Li, Ltd. Beigene, Ruirong Yuan, Thomas Malley, Corazon (Corsee) D. Sanders, Chan Henry Lee, and Amgen Inc
The most active insider trader at BeiGene Ltd is John Oyler with 58 trades.
Advisors Ltd. Hhlr has sold the most BeiGene Ltd stock with a total value of $611,648,230.34.
Bros. Advisors Lp Baker has bought the most BeiGene Ltd stock with a total value of $1,570,585,734.00.
The most recent insider trade for BeiGene Ltd was on April 10, 2024.
The single biggest insider buy for BeiGene Ltd was from Bros. Advisors Lp Baker with a total value of $627,922,800.00 on Aug. 2, 2018.
The single biggest insider sell for BeiGene Ltd was from Advisors Ltd. Hhlr with a total value of $253,876,785.50 on June 8, 2023.